Back to Cardiology
Cardiologyv2004Evidence-Based

Mehran Score for Post-PCI Contrast Nephropathy

Predicts risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI). The score uses 8 clinical variables to stratify patients into risk categories and guide preventive strategies.

Clinical Input Parameters

mL
Range: 0 — 1000 mL
mL/min/1.73 m²
Range: 0 — 200 mL/min/1.73 m²
Clinical Assessment
Awaiting Parameters
mehran score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Mehran Score for Post-PCI Contrast Nephropathy is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within cardiology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Score = Hypotension (5 points) + IABP (5 points) + CHF (5 points) + Age >75 (4 points) + Anemia (3 points) + Diabetes (3 points) + (Contrast volume in mL / 100) + eGFR points (6 if <20, 4 if 20-39, 2 if 40-59, 0 if ≥60)

Clinical Pearls & Practice Notes

  • CIN is defined as an increase ≥0.5 mg/dL (or ≥25%) in serum creatinine at 48 hours post-PCI.
  • Should not be used in patients with pre-existing end-stage renal disease on dialysis.
  • Should not be used in patients with contrast exposure within 1 week of the index procedure.
  • The score has been validated with excellent calibration and discriminatory capacity (C-statistic >0.8).
  • Consider renal protective measures such as N-acetylcysteine and limiting contrast volume in high-risk patients.
  • Hypotension criteria requires both SBP <80 mmHg AND need for inotropic support or IABP.

Evidence & Literature Citations

  1. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9. doi: 10.1016/j.jacc.2004.06.068.
  2. Wi J, Ko YG, Kim JS, Kim BK, Choi D, Ha JW, et al. Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart. 2011 Nov;97(21):1753-7. doi: 10.1136/hrt.2010.218677.
  3. Narula A, Mehran R, Weisz G, Dangas GD, Yu J, Généreux P, et al. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. Eur Heart J. 2014 Jun 14;35(23):1533-40. doi: 10.1093/eurheartj/ehu063.

Score Interpretation Ranges

Low Risk0 – 5 pts

Low risk of CIN

Moderate Risk6 – 10 pts

Moderate risk of CIN

High Risk11 – 15 pts

High risk of CIN

Very High Risk16 – 999 pts

Very high risk of CIN

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.